← Back
$XLO All transactions

Xilio Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$44K

Shares

5,000

Price

$9

Filed

Mar 30

Why this score? (8/10)
  • Open market buy (+3)
  • % of holdings >= 50% (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Shannon James Samuel

Title

CIK

0001485417

Roles

Director

Transaction Details

Transaction Date

2026-03-26

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.6758 to $9.2499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. | The number of shares beneficially owned reflects the 1-for-14 reverse stock split effected March 13, 2026.

Filing Info

Accession No.

0001193125-26-131745

Form Type

4

Issuer CIK

0001840233

Shannon James Samuel's History

Date Ticker Type Value
2026-03-26 XLO $44K
2025-06-17 XLO $17K
2025-06-16 XLO $31K
2025-06-11 XLO A $0
2025-05-14 MNKD A $0

Other Insiders at XLO (90d)

Insider Bought Sold Last
Blanchard Cheryl R 2026-04-15